BS

Boddu Sneha Latha

Director Director DIN 06385321
DIN 06385321 First appointment Jan 2013 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Boddu Sneha Latha

Data last updated:

Boddu Sneha Latha was a Director at Intelliscend Pharma Research And Consultancy Private Limited (2013–2019) and Director at Rsa Reesearch Private Limited (from 2013). The companies operate in Pharma.

DIN 06385321
Primary Designation Director
Industry Pharma
First Appointment 04 Jan 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Nov 20132013₹67.2 Lakh (FY 2023)Active
Rsa Reesearch Private Limited U73100MH2013PTC239295
Director04 Jan 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rsa Reesearch Private Limited
Intelliscend Pharma Research And Consultancy Private Limited
Premium access

Shareholding and investment profile for Boddu Sneha Latha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Boddu Sneha Latha

Boddu Sneha Latha was first appointed on 04 Jan 2013 as Director at Rsa Reesearch Private Limited.

Boddu Sneha Latha held 2 earlier board appointments: Intelliscend Pharma Research And Consultancy Private Limited (Director, 06 Nov 2013 to 20 Nov 2019); Rsa Reesearch Private Limited (Director, from 04 Jan 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available